Present indications for the use of breast MRI

Journal of Experimental and Clinical Cancer Research

Volumn 21, Issue 3 SUPPL., 2002, Pages 55-58

  Del Maschio, A ^a   De Gaspari, A ^a   Panizza, P ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Breast imaging; Breast implants; Breast MR; Breast neoplasms; MR guidance; Staging

Indexed keywords

BREAST; BREAST CANCER; BREAST PROSTHESIS; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL;

BREAST; BREAST DISEASES; BREAST IMPLANTS; BREAST NEOPLASMS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; SENSITIVITY AND SPECIFICITY;

EID: 0036767049     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (26)

1. Orel S.G., Schnall M.D.: MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology 220: 13-30, 2001.
2. Kuhl C.K., Mielcareck P., Klaschik S. et al.: Dynamic breast MR imaging: are signal intensity time course data usefull for differential diagnosis of enhancing lesions? Radiology 211: 101-110, 1999.
3. Hochman M.G., Orel S.G., Powell C.M., Schnall M.D., Reynolds C.A.: Fibroadenomas: MR imaging appearances with radiologic-histologic correlation. Radiology 204: 123-129, 1997.
4. Brinck U., Fischer U., Korabiowska M., Jutrowski M., Schauer A., Grabbe E.: The variability of fibroadenoma in contrastenhanced dynamic MR Mammography. A.J.R. Am. J. Roentgenol. 168: 1331-1334, 1997.
5. Orel S.G.: Differentiating benign from malignant enhancing lesions identified at MR imaging of the breast: are time signal intensity curves an accurate predictor?(editorial). Radiology 211: 5-7, 1999.
6. Liu P.F., Debatin J.F., Caduff R.F., et al: Improved diagnostic accuracy in dynamic contrast enhanced MRI of the breast by combined quantitative and qualitative analysis. Br. J. Radiol. 71: 501-509, 1998.
7. Solomon B., Orel S.G., Reynolds C., Schnall M.D.: Delayed development of enhancement in fat necrosis after breast conservation therapy: a potential pitfall of MR imaging of the breast. A.J.R. Am. J. Roentgenol. 170: 966-968, 1998.
8. Heywang-Koebrunner S.H., Schaumloeffel -Schulze U., Heinig A., Beck R.M., Lampe D., Buchmann J.: MR-guided percutaneous vacuum biopsy of breast lesions: experiences with 100 lesions (abstr). Radiology 213 (P): 289, 1999.
9. Kuhl C.K., Morakkabati N., Leutner C., et al.: MR imagingguided large-core (14 Gauge) needle biopsy of small lesions visible at breast MR imaging alone. Radiology 220: 31-39, 2001.
10. Orel S.G., Schnall M.D., Powell C.M., et al.: Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. Radiology 196: 115-122, 1995.
11. Gorczyca D.P., Sinha S., Ahn C.Y., et al: Silicone breast implants in vivo: MR imaging. Radiology 185: 407-410, 1992.
12. Ahn C.Y., Shaw W.W., Narayanan K., et al.: Definitive diagnosis of breast implant rupture using magnetic resonance imaging. Plast. Reconstr. Surg. 94(4): 681-691, 1993.
13. Heywang-koebrunner S.H., Schlegel A., Beck R., et al.: Contrast enhanced MRI of the breast after limited surgery and radiation therapy. J. Comput. Assist. Tomogr. 17:891-900, 1993.
14. Dao T.H., Rahmouni A., Campana F., et al.: Tumor recurrences versus fibrosis in the irradiated breast: differentiation with dynamic gadolinium enhanced MR imaging. Radiology 187: 752-755, 1993.
15. Gilles R., Guinebretiere J.M., Toussaint C., et al.: Locally advanced breast cancer: contrast enhanced subtraction MR imaging of response to preoperative chemotherapy. Radiology 191: 633-638, 1994.
16. Rieber A., Zeitler H., Rosenthal H., et al.:MRI of breast cancer: influence of chemotherapy on sensitivity. Br. J. Radiol. 70: 452-458, 1997.
17. Fischer U., Kopka L., Grabbe E.: Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 213: 881-888, 1999.
18. Essermann L., Hylton N., Yassa L., et al.: Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging. J. Clin. Oncol. 17: 110-119, 1999.
19. Mumtaz H., Hall-Craggs M.A., Davidson T., et al.: Staging of symptomatic primary breast cancer with MR imaging. A.J.R. Am. J. Roentgenol. 169: 417-424, 1997.
20. Slanetz P.J., Edmister W.B., Weisskoff R.M., et al.: Occult contralateral breast cancer detected by breasr MR (abstr.)Radiology 209: 416, 1998.
21. Morris E.A., Schwartz L.H., Dershaw D.D., et al.: MR imaging of the breast in patients with occult primary breast carcinoma. Radiology 205: 437-440, 1997.
22. Orel S.G., Weinstein S.P., Schnall M.D., et al.: Breast MR imaging in patients with axillary node metastases and unknown primary malignancy. Radiology 212: 543-549, 1999.
23. Shorn C., Fischer U., Luftner N., Westerhof J.P., Grabbe E.: MRI of the breast in patients with metastatic disease of unknown primary. Eur. Radiol. 9: 470-473, 1999.
24. Kuhl C.K., Schmutzer R.K., Leutner C.C., et al.: Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancers susceptibility gene: preliminary results. Radiology 215: 267-279, 2000.
25. Warner E., Plewes D.B., Shumak R.S., et al.: Comparison of breast magnetic resonance imaging, mammography and ultrasound for surveillance of women at high risk for hereditary breast cancer. J. Clin. Oncol. 19(15): 3524-3531, 2001.
26. Stoutjesdijk M.J., Boetes C., Jager G.J., et al.: Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. J. Natl. Cancer Inst. 93(14): 1095-1102, 2001.